SHANGHAI, Sept. 21, 2025 /PRNewswire/ — WuXi AppTec Co., Ltd. (Stock Codes: 603259.SH/2359.HK), a global company that provides a broad portfolio of R&D and manufacturing services to enable companies in the pharmaceutical and life science […]
Resilience
AusperBio Raises $63 Million in Series B2 Financing to Accelerate Functional Cure Therapies for Chronic Hepatitis B
SAN FRANCISCO, Sept. 21, 2025 /PRNewswire/ — AusperBio Therapeutics, Inc. and Ausper Biopharma Co., Ltd. (collectively AusperBio), a privately held clinical-stage biotechnology company dedicated to advancing targeted oligonucleotide therapies to achieve a functional cure for […]
Ascletis Announces ASC47 in Combination with Semaglutide Demonstrated Up to 56.2% Greater Relative Reduction in Body Weight in Participants with Obesity Compared to Semaglutide Monotherapy
– The gastrointestinal (GI) tolerability of ASC47 in combination with semaglutide was significantly better than placebo in combination with semaglutide (semaglutide monotherapy). The incidence of vomiting was 6.7% in ASC47 in combination with semaglutide group compared to 57.1% […]
Scientists Call for Urgent Action to Reduce Children's Plastic Exposure
NEW YORK, Sept. 21, 2025 /PRNewswire/ — Childhood exposure to chemicals used to make plastic household items presents growing health risks that can extend long into adulthood, experts from NYU Langone Health report. This is […]
SiBionics: Su CGM Cumple los Criterios de Control Especial para iCGM, Destacando Soluciones para la Diabetes en EASD 2025
VIENNA, 21 de septiembre de 2025 /PRNewswire/ — En la 61ª Reunión Anual de la Asociación EASD en Viena, la solución de gestión de la diabetes iCGM + CKM de SiBionics recibió un gran reconocimiento por […]
